Clinical challenges of chronic wounds: searching for an optimal animal model to recapitulate their complexity.

Nunan R, Harding KG, Martin P. · 2014

Read Clinical challenges of chronic wounds: searching for an optimal animal model to recapitulate their complexity. by Nunan R, Harding KG, Martin P. (2014) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4213725.txt.

Introduction

Robert Nunan, Keith G. Harding, and Paul Martin examined animal models of stubborn wounds in Disease Models and Mechanisms in 2014. Most cuts heal without thought, but chronic wounds in people with diabetes, obesity, or poor circulation can linger for months. Nearly all fall into three groups: leg ulcers, diabetic foot ulcers, and pressure ulcers.

Healthy wound healing is well mapped in animals, yet chronic wounds are not, because lab models rarely copy the human condition faithfully. The article walks through the best current models and names what each one misses. It then sets out how models could be improved, by combining age, poor blood flow, infection, and metabolic disease in one animal. Better models, the authors argue, are the route to treatments that work in the clinic.

Catalog record

CREATORNunan R, Harding KG, Martin P.
YEAR2014
COLLECTIONPAPERS
FORMATTXT
FILE SIZE53 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4213725

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Clinical challenges of chronic wounds: searching for an optimal animal model to recapitulate their complexity By Robert Nunan, Keith G. Harding, Paul Martin Published in: Disease Models & Mechanisms DOI: 10.1242/dmm.016782 ABSTRACT The efficient healing of a skin wound is something that most of us take for granted but is essential for surviving day-to-day knocks and cuts, and is absolutely relied on clinically whenever a patient receives surgical intervention. However, the management of a chronic wound – defined as a barrier defect that has not healed in 3 months – has become a major therapeutic challenge throughout the Western world, and it is a problem that will only escalate with the increasing incidence of conditions that impede wound healing, such as diabetes, obesity and vascular disorders. Despite being clinically and molecularly heterogeneous, all chronic wounds are generally assigned to one of three major clinical categories: leg ulcers, diabetic foot ulcers or pressure ulcers. Although we have gleaned much knowledge about the fundamental cellular and molecular mechanisms that underpin healthy, acute wound healing from various animal models, we have learned much less about chronic wound repair pathology from these models. This might largely be because the animal models being used in this field of research have failed to recapitulate the clinical features of chronic wounds. In this Clinical Puzzle article, we discuss the clinical complexity of chronic wounds and describe the best currently available models for investigating chronic wound pathology. We also assess how such models could be optimised to become more useful tools for uncovering pathological mechanisms and potential therapeutic treatments. CHRONIC WOUNDS: AN INTRODUCTION TO A GLOBAL CLINICAL PROBLEM Chronic, non-healing wounds (Box 1) can be debilitating for the affected individual and place a massive financial burden on healthcare systems. During the financial year 2005–2006, the total annual cost to Hull and East Yorkshire National Health Service (NHS) of treating chronic wounds was conservatively estimated at £15m–£18m (£2.5m–£3.1m per 100,000 population), which equates to about 2–3% of the local healthcare budget (Drew et al., 2007); these figures are likely to have escalated since this time. A recent study found a 4.2% prevalence rate of chronic wounds in a Dutch nursing-home population (Rondas et al., 2013). A typical hospital wound-healing clinic will see a large number, and a very variable range, of these lesions, but almost all chronic wounds will have a clear underlying cause and can generally be assigned to one of three clinical categories: leg ulcers, which are frequently a consequence of venous or arterial deficiencies [venous or arterial leg ulcer (VLU or ALU, respectively)]; diabetic foot ulcers (DFUs); or pressure ulcers (PUs), otherwise known as bed sores (Box 1; Fig. 1). [Figure: Flow diagram of chronic wound management. Skin lesions identified as chronic wounds are first classified into three broad categories (grey boxes): venous leg ulcers (VLUs), diabetic foot ulcers (DFUs) or pressure ulcers (PUs). Chronic wounds are then refined into sub-categories based on their suspected aetiology (blue boxes). All wounds are initially assumed to be ‘easy’ to treat and receive the appropriate care such as ‘offloading’, antibiotics or surgery. Subsequently, if healing fails, wounds receive progressively more aggressive treatment, including debridement and biological intervention. If all other treatment fails, the final resort is to amputate the affected appendage or limb.] Box 1. Clinical termsArterial disease:lack of blood supply through the arteries; common in diabetic individuals.Arterial leg ulcer (ALU):a leg ulcer caused by reduced arterial blood supply to the lower limb.Biofilm:a group of bacteria that adhere to each other and produce a protective ‘slime’.Bipedicle skin flaps:an area of tissue generated between two parallel incisions that retains a restricted supply of blood through a pedicle at each end.Chronic wound:a full-thickness skin defect that fails to heal within 3 months.Debridement:the act of removal of slough from chronic wounds with the aim of stimulating the healing process. This can be achieved via a variety of methods, including the use of a scalpel or larvae.Diabetes:a group of metabolic diseases that results in high blood-sugar levels, leading to complications that include blood vessel and nerve damage.Diabetic foot ulcer (DFU):this foot ulcer occurs in up to 15% of all individuals with diabetes and is caused by neural and vascular complications.Fibrin cuffs:build-up of fibrin around leg veins of patients with venous insufficiency. They can reduce diffusion of oxygen to surrounding tissue.Granulation tissue:formed during the repair process; comprised of mixed cell and tissue types, including new blood vessels, fibroblasts, myofibroblasts, matrix components and immune cells.Hyperoxia:higher than normal partial pressure of oxygen.Hypertension:high blood pressure.Hypoxia:low tissue oxygen tension.Ischemia:when blood flow to a tissue is restricted, leading to low oxygen and glucose levels.Offloading:a treatment for diabetic foot ulcer; involves sustained pressure relief from sites of injury.Osteomyelitis:infection of the bone.Pressure ulcers (PUs):these ulcers [also known as decubitus ulcers or bed sores] often occur over bony prominence owing to sustained pressure and/or shear/friction forces that obstruct blood flow to the tissue.Reperfusion injury:tissue injury caused by the return of blood supply after a period of ischemia.Transverse rectus abdominal myocutaneous (TRAM) flap:a musculocutaneous flap of skin remaining attached to the body through a single pedicle and used to generate necrotic skin by restricting blood flow.Vasculitis:abnormal and uncontrolled inflammation of blood vessels.Venous leg ulcer (VLU):a leg ulcer caused by sustained levels of high blood pressure in the lower leg due to inadequate venous return.Wound grading system (EPUAP):1 = non-blanchable erythema of intact skin; 2 = partial-thickness skin loss, involving epidermis, dermis, or both; 3 = full-thickness skin loss involving damage to or necrosis of subcutaneous tissue that can extend down to, but not through, underlying fascia; 4 = extensive destruction, tissue necrosis or damage to muscle, bone or supporting structures, with or without full-thickness skin loss. Leg ulcers Leg ulcers are a common chronic wound, with an incidence of 0.3% among the adult male population, rising to 8.3% of males over 85 (Moffatt et al., 2004). Their underlying cause can vary, but >70% are associated with venous disease, which features damage to the superficial and/or deep venous systems of the leg and consequently causes venous hypertension and reduced blood flow. This can result in the failure to heal even minor wounds to such limbs (Grey et al., 2006a). Other underlying causes of leg ulcers include arterial disease, vasculitis and skin malignancies [there is a well-established association between squamous cell carcinomas and chronic skin wounds (Enoch et al., 2004)]. Currently, the main treatment for VLUs is compression bandaging, which controls swelling and limits venous hypertension in the limb. This treatment can produce 70% ‘cure’ rates when employed in dedicated clinics; however, rates of this wound’s recurrence are high (Barwell et al., 2004). Diabetic foot ulcers A total of 15% of all individuals with diabetes will be affected by a foot ulcer (see case study in Box 2 and Fig. 2), generally in later life, and recurrence of these ulcers is seen in over 70% of patients within 5 years (Reiber et al., 1998; Apelqvist et al., 1993). Diabetes is a systemic disease that causes neuropathy and arterial damage, affecting many tissues and organs. Arguably, diabetic foot disease has the greatest clinical impact of all the medical complications associated with diabetes; indeed, 85% of diabetic limb amputations are preceded by an ulcer (Pecoraro et al.,

Read the complete text